Enovis Corporation (ENOV) Stock Price

ENOVStock

$25.58−19.82%52W

Market Cap$1.48B

P/E—

PEG Ratio3.45

Div yield—

Beta1.47

ENOV Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)2.98%

Price vs S&P 500 (4W)-17.65%

PEG Ratio3.45

VGM Score49.09

P/CF (Annual)6.53x

Book Value / Share (Quarterly)$25.61

P/TBV (Annual)6.02x

Revenue Growth (3Y)12.88%

Cash Flow / Share (Quarterly)$1.10

Price vs S&P 500 (YTD)-17.33%

Gross Margin (TTM)61.43%

Net Profit Margin (TTM)-47.97%

EPS (TTM)$-19.27

10-Day Avg Trading Volume0.85M

EPS Excl Extra (TTM)$-19.27

Revenue Growth (5Y)-6.05%

EPS (Annual)$-20.75

ROI (Annual)-42.51%

Gross Margin (Annual)58.16%

Net Profit Margin (5Y Avg)-17.93%

Cash / Share (Quarterly)$0.22

Revenue Growth QoQ (YoY)3.23%

ROA (Last FY)-30.89%

Revenue Growth TTM (YoY)4.89%

EBITD / Share (TTM)$-15.08

ROE (5Y Avg)-22.31%

Operating Margin (TTM)-45.14%

Cash Flow / Share (Annual)$0.35

P/B Ratio0.96x

P/B Ratio (Quarterly)0.88x

Net Income / Employee (Annual)$-151,800

EV / Revenue (TTM)1.17x

Net Interest Coverage (TTM)-32.29x

ROA (TTM)-27.77%

EV / EBITDA (TTM)75.04x

EPS Incl Extra (Annual)$-20.75

Current Ratio (Annual)2.02x

Quick Ratio (Quarterly)0.92x

3-Month Avg Trading Volume1.16M

52-Week Price Return-19.82%

EV / Free Cash Flow (Annual)135.09x

Revenue / Employee (TTM)$294,400

Tangible BV / Share (Quarterly)$5.67

P/S Ratio (Annual)0.63x

Asset Turnover (Annual)0.59x

52-Week High$34.28

Operating Margin (5Y Avg)-20.71%

EPS Excl Extra (Annual)$-20.75

CapEx CAGR (5Y)11.45%

26-Week Price Return14.23%

Quick Ratio (Annual)0.97x

13-Week Price Return2.52%

Total Debt / Equity (Annual)0.87x

Current Ratio (Quarterly)1.98x

Enterprise Value$2.69B

Revenue / Share Growth (5Y)-9.89%

Asset Turnover (TTM)0.58x

Book Value / Share Growth (5Y)-5.69%

Revenue / Employee (Annual)$288,100

Inventory Turnover (Annual)1.66x

Pretax Margin (Annual)-51.57%

Cash / Share (Annual)$0.64

3-Month Return Std Dev77.41%

Gross Margin (5Y Avg)56.70%

Net Income / Employee (TTM)$-141,200

EBITDA Interim CAGR (5Y)18.06%

ROE (Last FY)-79.51%

Net Interest Coverage (Annual)-30.84x

EPS Basic Excl Extra (Annual)$-20.75

P/FCF (TTM)15.34x

Receivables Turnover (TTM)5.13x

EV / Free Cash Flow (TTM)42.27x

Total Debt / Equity (Quarterly)0.87x

EPS Incl Extra (TTM)$-19.27

Receivables Turnover (Annual)5.29x

ROI (TTM)-37.56%

P/S Ratio (TTM)0.62x

Pretax Margin (5Y Avg)-20.64%

Revenue / Share (Annual)$39.39

Tangible BV / Share (Annual)$4.42

Forward P/E6.94x

Free OCF CAGR (5Y)-36.11%

Price vs S&P 500 (52W)-38.13%

Year-to-Date Return-5.37%

5-Day Price Return-1.68%

EPS Normalized (Annual)$-20.75

ROA (5Y Avg)-9.72%

Net Profit Margin (Annual)-52.69%

Month-to-Date Return-13.52%

Cash Flow / Share (TTM)$1.86

EBITD / Share (Annual)$-13.46

Operating Margin (Annual)-50.09%

LT Debt / Equity (Annual)0.85x

P/CF (TTM)5.25x

ROI (5Y Avg)-12.77%

LT Debt / Equity (Quarterly)0.84x

EPS Basic Excl Extra (TTM)$-19.27

P/TBV (Quarterly)3.96x

P/B Ratio (Annual)1.02x

Inventory Turnover (TTM)1.44x

Pretax Margin (TTM)-46.52%

Book Value / Share (Annual)$26.05

Price vs S&P 500 (13W)-0.27%

Beta1.47x

P/FCF (Annual)71.23x

Revenue / Share (TTM)$39.87

ROE (TTM)-68.17%

52-Week Low$19.14

vGradeB

gGradeD

mGradeC

vgmGradeC

ENOV Earnings Surprise History

Q2 250.79est. 0.72

Q3 250.75est. 0.65

Q4 250.95est. 0.84

Q1 260.89est. 0.81

Q2 260.90est. 0.85

ENOV Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.22

4.24

4.21

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
ENOVEnovis Corporation	B	D	C	$25.58
ISRGIntuitive Surgical Inc.	D	B	D	$371.84
EWEdwards Lifesciences Corp	D	C	B	$90.87
STESTERIS plc	C	B	C	$236.44
ZBHZimmer Biomet Holdings, Inc.	B	C	C	$100.24
SNNSmith & Nephew plc	B	C	D	$29.22
ALGNAlign Technology Inc	B	D	C	$159.61
MSAMine Safety Incorporated	C	C	C	$187.69
ESTAEstablishment Labs Holdings Inc.	F	A	C	$72.15
CDRECadre Holdings, Inc.	C	C	C	$31.39
AVNSAvanos Medical, Inc.	B	D	C	$24.99
AVRAnteris Technologies Global Corp. Common Stock	F	D	B	$8.89
SMTISanara MedTech Inc. Common Stock	D	C	B	$34.67
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	B	D	C	$2.77
CNXUConexeu Sciences Inc. Common Stock	—	—	F	$7.55
INGNInogen Inc	B	D	D	$5.54
LAKELakeland Industries Inc	B	D	C	$11.52
SPAISafe Pro Group Inc. Common Stock	F	C	B	$5.25
NTRBNutriband Inc. Common Stock	F	D	B	$4.83
MYOMyomo Inc.	C	B	B	$1.48
COCHEnvoy Medical, Inc. Class A Common Stock	D	D	C	$0.75
APTAlpha Pro Tech, Ltd.	A	D	C	$5.36
MLSSMilestone Scientific, Inc. Common Stock	D	D	B	$0.48
LFWDLifeward Ltd. Ordinary Shares	B	D	C	$7.39
RGNTRegentis Biomaterials Ltd.	—	—	C	$2.09
HSCSHeartSciences Inc. Common Stock	F	F	B	$3.00
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	C	$2.92
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	C	F	F	$0.29
FEEDENvue Medical, Inc. Common Stock	A	F	F	$0.39
BBLGBone Biologics Corp Common Stock	—	—	F	$0.60
BBLGWBone Biologics Corp Warrants	—	—	D	$8.24
COCHWEnvoy Medical, Inc Warrant	—	—	F	$0.04
HSCSWHeartSciences Inc. Warrant	—	—	F	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	$0.50

About Enovis Corporation

Enovis manufactures orthopedic and rehabilitation devices for reconstructive surgery, injury prevention, and pain management. The company serves orthopedic specialists, primary care physicians, physical therapists, and athletic trainers, addressing musculoskeletal conditions ranging from sports injuries and deformities to degenerative diseases. Its Prevention & Recovery segment, which represents the majority of revenue, provides post-surgical rehabilitation and chronic condition management solutions.